Inogen (INGN) Non-Current Deffered Revenue (2013 - 2026)
Inogen (INGN) reported Non-Current Deffered Revenue of $3.2 million for Q1 2026, down 37.93% year-over-year from $5.1 million in Q1 2025, and down 12.02% on a QoQ basis from $3.6 million in Q4 2025.
Inogen (INGN) has 14 years of Non-Current Deffered Revenue data on file, last reported at $3.2 million in Q1 2026.
- Quarterly Non-Current Deffered Revenue fell 37.93% year-over-year to $3.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.2 million (down 37.93% YoY) and the FY2025 annual result came in at $3.6 million, down 37.31% from the prior year.
- Non-Current Deffered Revenue retreated to $3.2 million in Q1 2026 per INGN's latest filing, from $3.6 million in the prior quarter.
- Across five years, Non-Current Deffered Revenue topped out at $11.5 million in Q1 2022 and bottomed at $3.2 million in Q1 2026.
- The 5-year median for Non-Current Deffered Revenue is $7.6 million (2024), against an average of $7.5 million.
- The widest annual swing landed in 2022, when Non-Current Deffered Revenue dropped 2.81%; it then plunged 37.93% in 2026.
- Tracing INGN's Non-Current Deffered Revenue over 5 years: stood at $10.4 million in 2022, then fell by 20.89% to $8.2 million in 2023, then sank by 30.14% to $5.7 million in 2024, then tumbled by 37.31% to $3.6 million in 2025, then decreased by 12.02% to $3.2 million in 2026.
- Per Business Quant, the three latest INGN Non-Current Deffered Revenue figures stand at $3.2 million (Q1 2026), $3.6 million (Q4 2025), and $4.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 512.79 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Inogen | 165.85 Mn | 71.44 Mn | 37.86 Mn | 3.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.17 Mn |
| Dec 31, 2025 | 3.60 Mn |
| Sep 30, 2025 | 4.08 Mn |
| Jun 30, 2025 | 4.59 Mn |
| Mar 31, 2025 | 5.11 Mn |
| Dec 31, 2024 | 5.75 Mn |
| Sep 30, 2024 | 6.44 Mn |
| Jun 30, 2024 | 7.07 Mn |
| Mar 31, 2024 | 7.61 Mn |
| Dec 31, 2023 | 8.23 Mn |
| Sep 30, 2023 | 8.88 Mn |
| Jun 30, 2023 | 9.35 Mn |
| Mar 31, 2023 | 9.80 Mn |
| Dec 31, 2022 | 10.40 Mn |
| Sep 30, 2022 | 11.03 Mn |
| Jun 30, 2022 | 11.40 Mn |
| Mar 31, 2022 | 11.51 Mn |
| Dec 31, 2021 | 11.86 Mn |
| Sep 30, 2021 | 12.14 Mn |
| Jun 30, 2021 | 12.19 Mn |
| Mar 31, 2021 | 11.84 Mn |
| Dec 31, 2020 | 11.82 Mn |
| Sep 30, 2020 | 12.77 Mn |
| Mar 31, 2020 | 13.21 Mn |
| Dec 31, 2019 | 13.54 Mn |
| Sep 30, 2019 | 13.29 Mn |
| Jun 30, 2019 | 12.64 Mn |
| Mar 31, 2019 | 11.38 Mn |
| Dec 31, 2018 | 11.84 Mn |
| Sep 30, 2018 | 12.78 Mn |
| Jun 30, 2018 | 11.71 Mn |
| Mar 31, 2018 | 10.39 Mn |
| Dec 31, 2017 | 9.40 Mn |
| Sep 30, 2017 | 8.62 Mn |
| Jun 30, 2017 | 7.92 Mn |
| Mar 31, 2017 | 7.14 Mn |
| Dec 31, 2016 | 7.04 Mn |
| Sep 30, 2016 | 6.34 Mn |
| Jun 30, 2016 | 5.62 Mn |
| Mar 31, 2016 | 4.77 Mn |
| Dec 31, 2015 | 4.20 Mn |
| Sep 30, 2015 | 3.70 Mn |
| Jun 30, 2015 | 3.16 Mn |
| Mar 31, 2015 | 2.47 Mn |
| Dec 31, 2014 | 2.18 Mn |
| Sep 30, 2014 | 1.88 Mn |
| Jun 30, 2014 | 1.55 Mn |
| Mar 31, 2014 | 1.10 Mn |
| Dec 31, 2013 | 776,000.00 |